CAR-T cell therapy, originally developed for cancer, is showing ever more promise as a treatment for autoimmune diseases.

A new study co-led by the Institute for Systems Biology (ISB) shows that some lung cancers can change identity as they evolve, shifting from one cancer type to another in ways that may make them more ...

Discover how cybercriminals in Nigeria use fake medical stories and pity to perpetrate charity scams, exploiting public ...

Reflex molecular testing and nurse navigation cut delays in lung cancer care, helping more patients get targeted results ...

High levels of residential radon were linked to a roughly 30% higher risk for ovarian cancer in postmenopausal women, an ...

Since 2017, a personalized immunotherapy called Chimeric Antigen Receptor, or CAR-T cell treatment, has worked wonders to ...

Leah Phillips never smoked and doctors thought her symptoms were due to a cold or allergies. Given a terminal lung cancer ...

Surgical treatment for early-stage non-small cell lung cancer (NSCLC) is associated with similarly favorable safety and ...

A shared decision-making aid can be beneficial during the treatment process for patients with lung cancer, according to a ...

Former Sen. Ben Sasse (R-Neb.) detailed his battle with cancer and reflected on his life during a wide-ranging interview with ...

Lung cancer remains one of the leading causes of cancer-related mortality globally, and immunotherapy has significantly reshaped therapeutic possibilities.

AI models can generate more complete summaries of complex cancer pathology reports than physicians, according to a new Northwestern Medicine study that tested six models developed by Meta, Google, ...